In fact, according to other studies, patients with NSCLC with greater increases in PD-1+ CD8+ TCR repertoire clonality intra and post-ICI presented greater PFS and OS, reflecting an expansion of a successful anti-tumoral clonotype. Here, CD8A is linked to non-small cell lung carcinoma.